FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386373003> ?p ?o ?g. }

• W4386373003 abstract "Abstract Background A predominant side effect of radiotherapy for head and neck cancer is salivary gland hypofunction and xerostomia leading to debilitating oral disorders and impaired quality of life (QoL). Intraglandular mesenchymal stem cell therapy has shown promising results as a treatment for xerostomia. Methods This is a randomised, double-blinded, placebo-controlled, parallel-group, prospective, single-centre trial investigating the safety, tolerability, and effectiveness of allogeneic stem cells as a treatment for radiation-induced hyposalivation and xerostomia for previous head and neck cancer patients. We will include a total of 120 patients who previously have been treated with radiotherapy for a head and neck cancer in Denmark. Participants will be randomly assigned using block randomisation to one of two parallel groups in a 1:1 ratio to receive ultrasound-guided injection of allogeneic adipose-derived mesenchymal stem cell (ASC) ( n = 60) or placebo ( n = 60) into the submandibular glands. Placebo will consist of CryoStor10 (BiolifeSolutions), the freeze media for ASCs containing 10% dimethyl sulfoxide (DMSO). The primary endpoint is change in unstimulated whole saliva flow rate. The secondary endpoints are change in stimulated whole saliva flow rate, QoL, and composition of saliva. Further secondary endpoints are safety and immune response (human leukocyte antigen (HLA) response) to the stem cells will be assessed. Patients are evaluated at baseline (before treatment), after 4 months, and after 12 months. All study personnel, except study personnel thawing and preparing the treatment for injection, and participants will be blinded to group assignment. Unblinded study personnel will not participate in the outcome assessment. Discussion The trials will investigate the efficacy and safety of ASC injection to the submandibular gland as a potential new treatment for post-radiation xerostomia. We hope the results will pave the way for a clinically relevant treatment to ameliorate patients with xerostomia, a severely hampering condition. Trial registration The study is approved by the Danish Data Protection Agency (protocol number P-2020-1164), the National Ethics Committee protocol number: (Protocol number: 1802872), and the Danish Medical Agency (2018-000348-24). The protocol was registered at the ClinicalTrials.gov database (NCT04776538)." @default.
• W4386373003 created "2023-09-02" @default.
• W4386373003 creator A5003618430 @default.
• W4386373003 creator A5010676985 @default.
• W4386373003 creator A5015559691 @default.
• W4386373003 creator A5025232707 @default.
• W4386373003 creator A5034854398 @default.
• W4386373003 creator A5043389407 @default.
• W4386373003 creator A5046474089 @default.
• W4386373003 creator A5049494918 @default.
• W4386373003 creator A5057144939 @default.
• W4386373003 creator A5069420349 @default.
• W4386373003 creator A5075994006 @default.
• W4386373003 creator A5077250723 @default.
• W4386373003 creator A5077475547 @default.
• W4386373003 creator A5087463597 @default.
• W4386373003 creator A5092730067 @default.
• W4386373003 date "2023-09-01" @default.
• W4386373003 modified "2023-09-30" @default.
• W4386373003 title "Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study" @default.
• W4386373003 cites W1541104889 @default.
• W4386373003 cites W1925560926 @default.
• W4386373003 cites W2007098561 @default.
• W4386373003 cites W2007829215 @default.
• W4386373003 cites W2029833407 @default.
• W4386373003 cites W2044233644 @default.
• W4386373003 cites W2046916147 @default.
• W4386373003 cites W2076704745 @default.
• W4386373003 cites W2092685863 @default.
• W4386373003 cites W2103127964 @default.
• W4386373003 cites W2105605694 @default.
• W4386373003 cites W2108471042 @default.
• W4386373003 cites W2113511308 @default.
• W4386373003 cites W2117689681 @default.
• W4386373003 cites W2134682009 @default.
• W4386373003 cites W2161434409 @default.
• W4386373003 cites W2166023752 @default.
• W4386373003 cites W2175829306 @default.
• W4386373003 cites W2554218492 @default.
• W4386373003 cites W2591715937 @default.
• W4386373003 cites W2605574960 @default.
• W4386373003 cites W2639623121 @default.
• W4386373003 cites W2751753120 @default.
• W4386373003 cites W2791805108 @default.
• W4386373003 cites W2793668866 @default.
• W4386373003 cites W4214837548 @default.
• W4386373003 doi "https://doi.org/10.1186/s13063-023-07594-5" @default.
• W4386373003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37658468" @default.
• W4386373003 hasPublicationYear "2023" @default.
• W4386373003 type Work @default.
• W4386373003 citedByCount "0" @default.
• W4386373003 crossrefType "journal-article" @default.
• W4386373003 hasAuthorship W4386373003A5003618430 @default.
• W4386373003 hasAuthorship W4386373003A5010676985 @default.
• W4386373003 hasAuthorship W4386373003A5015559691 @default.
• W4386373003 hasAuthorship W4386373003A5025232707 @default.
• W4386373003 hasAuthorship W4386373003A5034854398 @default.
• W4386373003 hasAuthorship W4386373003A5043389407 @default.
• W4386373003 hasAuthorship W4386373003A5046474089 @default.
• W4386373003 hasAuthorship W4386373003A5049494918 @default.
• W4386373003 hasAuthorship W4386373003A5057144939 @default.
• W4386373003 hasAuthorship W4386373003A5069420349 @default.
• W4386373003 hasAuthorship W4386373003A5075994006 @default.
• W4386373003 hasAuthorship W4386373003A5077250723 @default.
• W4386373003 hasAuthorship W4386373003A5077475547 @default.
• W4386373003 hasAuthorship W4386373003A5087463597 @default.
• W4386373003 hasAuthorship W4386373003A5092730067 @default.
• W4386373003 hasBestOaLocation W43863730031 @default.
• W4386373003 hasConcept C121608353 @default.
• W4386373003 hasConcept C126322002 @default.
• W4386373003 hasConcept C141071460 @default.
• W4386373003 hasConcept C142724271 @default.
• W4386373003 hasConcept C143998085 @default.
• W4386373003 hasConcept C197934379 @default.
• W4386373003 hasConcept C198826908 @default.
• W4386373003 hasConcept C203092338 @default.
• W4386373003 hasConcept C204787440 @default.
• W4386373003 hasConcept C27081682 @default.
• W4386373003 hasConcept C2776530083 @default.
• W4386373003 hasConcept C2778375690 @default.
• W4386373003 hasConcept C28328180 @default.
• W4386373003 hasConcept C504460877 @default.
• W4386373003 hasConcept C509974204 @default.
• W4386373003 hasConcept C535046627 @default.
• W4386373003 hasConcept C54355233 @default.
• W4386373003 hasConcept C71924100 @default.
• W4386373003 hasConcept C86803240 @default.
• W4386373003 hasConceptScore W4386373003C121608353 @default.
• W4386373003 hasConceptScore W4386373003C126322002 @default.
• W4386373003 hasConceptScore W4386373003C141071460 @default.
• W4386373003 hasConceptScore W4386373003C142724271 @default.
• W4386373003 hasConceptScore W4386373003C143998085 @default.
• W4386373003 hasConceptScore W4386373003C197934379 @default.
• W4386373003 hasConceptScore W4386373003C198826908 @default.
• W4386373003 hasConceptScore W4386373003C203092338 @default.
• W4386373003 hasConceptScore W4386373003C204787440 @default.
• W4386373003 hasConceptScore W4386373003C27081682 @default.
• W4386373003 hasConceptScore W4386373003C2776530083 @default.
• W4386373003 hasConceptScore W4386373003C2778375690 @default.
• W4386373003 hasConceptScore W4386373003C28328180 @default.

• next